Evidence map›Paper›PMID 36329870›Full record

ArticleIEEE access : practical innovations, open solutions2020

Clustering Sparse Data With Feature Correlation With Application to Discover Subtypes in Cancer.

Jipeng Qiang, Wei Ding, Marieke Kuijjer, John Quackenbush, Ping Chen

Abstract read
In one paragraph

Article in IEEE access : practical innovations, open solutions, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. One-Step Robust Low-Rank Subspace Segmentation for Tumor Sample Clustering.Computational intelligence and neuroscience · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jipeng QiangDepartment of Computer Science, Yangzhou University, Yangzhou 225127, China.ORCID 0000-0001-8036-9550
Wei DingDepartment of Computer Science, University of Massachusetts Boston, Boston, MA 02125, USA.ORCID 0000-0002-3383-551X
Marieke KuijjerCentre for Molecular Medicine Norway, University of Oslo Faculty of Medicine, 0318 Oslo, Norway.ORCID 0000-0001-6280-3130
John QuackenbushDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-2702-5879
Ping ChenDepartment of Computer Science, University of Massachusetts Boston, Boston, MA 02125, USA.ORCID 0000-0003-3789-7686

Funding

Unraveling the Complexities of Risk and Mechanism in CancerR35CA220523 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI QUACKENBUSH, JOHN · 2018 to 2024
$6.0M
NCI NIH HHS R35 CA220523
6 · The paper itself

Abstract

In this paper, given data with high-dimensional features, we study this problem of how to calculate the similarity between two samples by considering feature interaction network, where a feature interaction network represents the relationship between features. This is different from some traditional methods, those of which learn similarities based on a sample network that represents the relationship between samples. Therefore, we propose a novel network-based similarity metric for computing the similarity between samples, which incorporates the knowledge of feature interaction network, in order to overcome the data sparseness problem. Our similarity metric uses a new Feature Alignment Similarity measure, which does not directly compute the similarities among samples, but projects each sample into a feature interaction network and measures the similarities between two samples using the similarities between the vertices of the samples in the network. As such, when two samples do not share any common features, they are likely to have higher similarity values when their features share the similar network regions. For ensuring that the metric is useful in a real-world application, we apply our metric to discover subtypes in tumor mutational data by incorporating the information of the gene interaction network. Our experimental results from using synthetic data and real-world tumor mutational data show that our approach outperforms the top competitors in cancer subtype discovery. Furthermore, our approach can identify cancer subtypes that cannot be detected by other clustering algorithms in real cancer data.

Indexed as

Cancer subtypefeature interaction networksimilarity metricsomatic mutational data

Identifiers

PMID36329870
PMCPMC9629797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.